CY1116238T1 - Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium - Google Patents

Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium

Info

Publication number
CY1116238T1
CY1116238T1 CY20151100392T CY151100392T CY1116238T1 CY 1116238 T1 CY1116238 T1 CY 1116238T1 CY 20151100392 T CY20151100392 T CY 20151100392T CY 151100392 T CY151100392 T CY 151100392T CY 1116238 T1 CY1116238 T1 CY 1116238T1
Authority
CY
Cyprus
Prior art keywords
compounds
against clostridium
activity against
bacterial activity
clostridium
Prior art date
Application number
CY20151100392T
Other languages
English (en)
Inventor
Jérôme Emile Georges Guillemont
Pierre Jean-Marie Bernard Raboisson
Nacer Lounis
Original Assignee
Elanco Animal Health Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Ireland Limited filed Critical Elanco Animal Health Ireland Limited
Publication of CY1116238T1 publication Critical patent/CY1116238T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με καινοφανείς ενώσεις του τύπου (I) οι οποίες έχουν αντιβακτηριακή δραστικότητα έναντι βακτηρίων Clostridium, ιδιαίτερα έναντι Clostridium perfringens, με φαρμακευτικές συνθέσεις που περιλαμβάνουν αυτές τις ενώσεις, και με χημικές διεργασίες παρασκευής αυτών των ενώσεων.
CY20151100392T 2010-08-04 2015-04-30 Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium CY1116238T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171842 2010-08-04
EP11740921.9A EP2601193B1 (en) 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium

Publications (1)

Publication Number Publication Date
CY1116238T1 true CY1116238T1 (el) 2017-02-08

Family

ID=43125618

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100392T CY1116238T1 (el) 2010-08-04 2015-04-30 Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium

Country Status (28)

Country Link
US (1) US8618100B2 (el)
EP (1) EP2601193B1 (el)
JP (1) JP5886285B2 (el)
KR (1) KR101499368B1 (el)
CN (1) CN103038234B (el)
AR (1) AR082472A1 (el)
AU (1) AU2011287584B2 (el)
BR (1) BR112013003675A8 (el)
CA (1) CA2805358C (el)
CL (1) CL2013000331A1 (el)
CO (1) CO6680629A2 (el)
CY (1) CY1116238T1 (el)
DK (1) DK2601193T3 (el)
EA (1) EA021567B1 (el)
ES (1) ES2538998T3 (el)
HK (1) HK1180690A1 (el)
HR (1) HRP20150467T1 (el)
ME (1) ME02061B (el)
MX (1) MX2013001246A (el)
NZ (1) NZ605850A (el)
PL (1) PL2601193T3 (el)
PT (1) PT2601193E (el)
RS (1) RS53990B1 (el)
SG (1) SG187175A1 (el)
SI (1) SI2601193T1 (el)
TW (1) TWI498330B (el)
WO (1) WO2012017030A1 (el)
ZA (1) ZA201300432B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
WO2016127102A2 (en) * 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5247705B2 (ja) * 2006-09-26 2013-07-24 クレストーン・インコーポレーテッド 抗細菌活性を持つ置換チエノピリドン化合物
ES2429289T3 (es) * 2006-09-26 2013-11-14 Crestone, Inc. Compuestos enantioméricos con actividad antibacteriana
WO2008039642A2 (en) 2006-09-26 2008-04-03 Replidyne, Inc. Methods and compounds for treatment of clostridium based infection

Also Published As

Publication number Publication date
ZA201300432B (en) 2014-08-27
DK2601193T3 (en) 2015-03-23
TWI498330B (zh) 2015-09-01
WO2012017030A1 (en) 2012-02-09
JP2013532714A (ja) 2013-08-19
AU2011287584B2 (en) 2014-05-01
CO6680629A2 (es) 2013-05-31
MX2013001246A (es) 2013-03-21
EP2601193B1 (en) 2015-03-11
EP2601193A1 (en) 2013-06-12
CN103038234B (zh) 2016-02-24
ME02061B (me) 2015-05-20
JP5886285B2 (ja) 2016-03-16
EA201270817A1 (ru) 2013-05-30
TW201211048A (en) 2012-03-16
BR112013003675A8 (pt) 2017-12-26
PL2601193T3 (pl) 2015-08-31
AU2011287584A1 (en) 2013-02-07
CA2805358A1 (en) 2012-02-09
SG187175A1 (en) 2013-02-28
US20130109694A1 (en) 2013-05-02
SI2601193T1 (sl) 2015-05-29
EA021567B1 (ru) 2015-07-30
ES2538998T3 (es) 2015-06-25
US8618100B2 (en) 2013-12-31
HK1180690A1 (en) 2013-10-25
PT2601193E (pt) 2015-05-18
CA2805358C (en) 2016-02-16
BR112013003675A2 (pt) 2016-09-06
NZ605850A (en) 2014-07-25
CN103038234A (zh) 2013-04-10
HRP20150467T1 (hr) 2015-06-05
KR101499368B1 (ko) 2015-03-05
KR20130033440A (ko) 2013-04-03
RS53990B1 (en) 2015-10-30
CL2013000331A1 (es) 2013-06-28
AR082472A1 (es) 2012-12-12

Similar Documents

Publication Publication Date Title
UA107791C2 (en) Pesticidal compositions
MX2011005934A (es) Compuestos organicos.
IN2015DN00960A (el)
BR112014017968A8 (pt) Compostos de beta-lactama substituídos por amidina, sua preparação e uso como agentes antibacterianos
IN2014DN09346A (el)
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
GEP20135964B (en) Inhibitors of beta-secretase
MY153915A (en) Organic compounds
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
TR201902788T4 (tr) Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri.
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
MX2013009252A (es) Composiciones y procesos relacionados con los mismos plaguicidas.
CY1114883T1 (el) Καινοφανεις αντιβακτηριακοι παραγοντες για την αγωγη των κατα gram θετικων λοιμωξεων
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
BR112012026147A2 (pt) espiroderivados azacíclicos como inibidores de hsl
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
EA201490435A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные пиперидинилом
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
CY1116238T1 (el) Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium
EA201590339A1 (ru) Новые антибактериальные соединения
CY1119470T1 (el) Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη
EA201590331A1 (ru) Новые антибактериальные соединения